Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ChromaCode, Inc. logo — REDEFINING MOLECULAR TESTING THROUGH DATA SCIENCE

ChromaCode, Inc.

REDEFINING MOLECULAR TESTING THROUGH DATA SCIENCE

Founded 2012 United States Carlsbad, United States 18 employees Total: $56.00M Biotechnology, Health Care

General Information

Company Name ChromaCode, Inc.
Founded Year 2012
Location United States Carlsbad, United States
Employees 18
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with ChromaCode, Inc.. To contact ChromaCode, Inc., visit chromacode.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ChromaCode, Inc.

ChromaCode, Inc., founded in 2012, is a pioneering United States-based firm in the Biotechnology and Health Care sectors. With a slogan of "REDEFINING MOLECULAR TESTING THROUGH DATA SCIENCE," the company harnesses advanced bioinformatics to revolutionize molecular diagnostics.

Drawing expertise from pedigrees like Illumina, Google[x], Luminex, and Caltech, ChromaCode employs proprietary mathematical methods to bolster signal processing in life science instrumentation. By extracting novel biochemical data, they aim to enhance the efficiency and reduce the cost of standard biochemical assays.

After securing a Series D investment on 07 June 2023 from investor Global Brain, the company is poised for robust growth. Their innovative approach contributes to a competitive edge in the rapidly evolving diagnostics market, making them an attractive prospect for long-term investment.

Taxonomy: molecular diagnostics, bioinformatics, data science, algorithmic enhancements, biochemistry reactions, signal processing, life science instrumentation, startups, innovation, biomedical engineering

Services & Products

HDPCR Multiplexing Platform
Genomic Solutions
Reagent Kits
Cloud-Based Software

Target Customers

Physicians Laboratories Healthcare Providers Oncology Practitioners

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC Undisclosed 2
Global Brain SHIMADZU CORPORATION
Global Brain, SHIMADZU CORPORATION
01 Jun 2023
Grant $6.00M 1
X PRIZE Foundation
01 Mar 2021
Series C $10.00M 6
Okapi Venture Capital Domain Associates Adjuvant Capital
Okapi Venture Capital, Domain Associates +4
01 May 2020
Series C $28.00M 6
Okapi Venture Capital Domain Associates Windham Venture Partners
Okapi Venture Capital, Domain Associates +4
01 Dec 2019
Series B $12.00M 3
Okapi Venture Capital Domain Associates NEA
Okapi Venture Capital, Domain Associates +1
01 Apr 2017

ChromaCode, Inc. Alternatives & Competitors

View All Alternatives
ChromaCode, Inc. vs
AmplifiDx
AmplifiDx United States

The Might of Molecular

Seed
12 employees
Biotechnology, Health Care
ChromaCode, Inc. vs
Longhorn Vaccines and Diagnostics, LLC
Longhorn Vaccines and Diagnostics, LLC United States

Longhorn Vaccines & Diagnostics is an innovative molecular tool, assay and vaccine development compa...

14 employees
Biotechnology, Health Care
ChromaCode, Inc. vs
Geneplus-Beijing Co. Ltd.
Geneplus-Beijing Co. Ltd.

Pioneering innovative molecular biological solutions for life science and diagnostics

Series C
Biotechnology, Health Care
View all alternatives

FAQ About ChromaCode, Inc.

REDEFINING MOLECULAR TESTING THROUGH DATA SCIENCE
ChromaCode, Inc. was founded in 2012.
ChromaCode, Inc. is headquartered in Carlsbad, United States.
ChromaCode, Inc. operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, bioinformatics, data science and algorithmic enhancements. Its customers include Physicians, Laboratories and Healthcare Providers.
ChromaCode, Inc. has approximately 18 employees.
ChromaCode, Inc. has completed 5 funding rounds, raising a total of $56.00M.
ChromaCode, Inc. offers: HDPCR Multiplexing Platform, Genomic Solutions, Reagent Kits, Cloud-Based Software.
Top alternatives and competitors to ChromaCode, Inc. include AmplifiDx, Longhorn Vaccines and Diagnostics, LLC, Geneplus-Beijing Co. Ltd., Biogenes Technologies, Ad Astra Diagnostics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ChromaCode, Inc. and AmplifiDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ChromaCode, Inc., https://bouncewatch.com/company/chromacode-inc, updated 23 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes